Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections

International Journal of Antimicrobial Agents

Volumn 24, Issue 5, 2004, Pages 515-518

  Blandino, G ^a   Marchese, A ^b   Ardito, F ^c   Fadda, G ^c   Fontana, R ^d   Cascio, G Lo ^d   Marchetti, F ^e   Schito, G C ^b   Nicoletti, G ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e GLAXOSMITHKLINE   (United States)

Author keywords

In vitro; Intensive care units; Lower respiratory tract infections; Surveillance

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD SAMPLING; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; INTENSIVE CARE UNIT; ITALY; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; ITALY; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 7044235799     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.10.015     Document Type: Article

References (18)

1. J.L. Vincent, D.J. Bihari, and P.M. Suter The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee J Am Med Assoc 274 1995 639 644
2. E. Nicastri, L. Martini, M. Larosa the Inf-Nos Study Group Multicentre Prevalence Survey of Nosocomial Infections in Italy A report from the 42th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) American Society for Microbiology, Abstracts, San Diego, CA: 27-30 September 2002 333
3. E. Nicastri, L. Martini, Larosa the Inf-Nos Study Group Prevalence of nosocomial infections in Italy: results from a multicentre national study Fifth International Conference of the Hospital Infection Society Edinburgh, 15-18 September 2002 20 28 poster
4. R. Fontana, G. Lo Cascio, and M. Ligozzi Antimicrobial susceptibility of respiratory isolates of Enterobacteriaceae and Staphylococcus aureus in Italy: incidence and trends over the period Eur J Clin Microbiol Infect Dis. 20 2001 854 863
5. A. Marchese, E. Tonoli, and G. Balistreri Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy Microb Drug Resistance 6 2000 163 170
6. Nicoletti G, Blandino G, Caccamo F, et al. The Italian Epidemiological Observatory - The Italian Epidemiological Survey 1997-1999. Antimicrobial susceptibility data of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis in Italy.
7. T. Spanu, A.F. Ardito, and G. Fadda Attivit in vitro di β-lattamici, aminoglicosidi, ciprofloxacina, e cotrimossazolo contro batteri gram negativi non fermentanti isolati da secrezioni respiratorie Microbiologia Medica 12 Suppl 4 1997 S21 S26
8. T. Spanu, A.F. Ardito, and G. Velardi Attivit in vitro di beta-lattamici, aminoglicosidi e ciprofloxacina nei confronti di 515 ceppi di Pseudomonas aeruginosa isolati dalle secrezioni respiratorie di pazienti ospedalizzati Microbiologia Medica 14 Suppl 1 1999 S1 S11
9. D. Felmingham, R.N. Gruneberg the Alexander Project Group A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project J Antimicrob Chemother. 38 Suppl A 1996 1 57
10. P.R. Murray, E.J. Boom, and M.D. Pfaller Manual of Clinical Microbiology 7th ed. 1999 American Society for Microbiology Washington, D.C.
11. National Committee for Clinical Laboratory Standards. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th edition. M100-S10 (M7), NCCLS, Wayne, PA, 2000.
12. G. Bonfiglio, V. Carciotto, and G. Russo Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey J Antimicrob Chemother. 41 1998 307 310
13. G.P. Gesu, F. Marchetti, and L. Piccoli Levofloxacin and ciprofloxacin in vitro activity on 4003 bacterial clinical isolates collected in 24 Italian laboratories Antimicrob Agents Chemother. 47 2003 816 819
14. G. Bonfiglio, and F. Marchetti In vitro activity of ceftazidime, cefepime and imipenem on 1005 P. aeruginosa clinical isolates either susceptible or resistant to beta-lactams Chemotherapy 46 2000 229 234
15. B. Segatore, D. Setacci, and M. Perilli Italian survey on the comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa Antimicrob Agents Chemother. 43 1999 428 431
16. G. Bonfiglio, Y. Laksai, and L. Franchino Mechanisms of β-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey J Antimicrob Chemother 42 1998 697 702
17. A. Marchese, E. Debbia, and D. Bacca Multidrug-resistant Gram positive pathogens: an update on current microbiological patterns Drugs 54 Suppl 6 1997 11 20
18. P. Periti, P. Nicoletti, and A.R. De Gaudio La chemiotherapia antimicrobica nelle Unit di Terapia Intensiva Farmaci e Terapia. XVII-3/4 2000 161 174